IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i11p5748-d563349.html
   My bibliography  Save this article

SARS-CoV-2 vs. Hepatitis Virus Infection Risk in the Hemodialysis Population: What Should We Expect?

Author

Listed:
  • Luis D’Marco

    (Nephrology Department, Hospital Clínico Universitario (INCLIVA), 46010 Valencia, Spain
    School of Medicine, Universidad de Valencia, 46010 Valencia, Spain)

  • María Jesús Puchades

    (Nephrology Department, Hospital Clínico Universitario (INCLIVA), 46010 Valencia, Spain
    School of Medicine, Universidad de Valencia, 46010 Valencia, Spain)

  • Miguel Ángel Serra

    (School of Medicine, Universidad de Valencia, 46010 Valencia, Spain
    Digestive Medicine Department, Hospital Clínico Universitario de Valencia, 46010 València, Spain)

  • Lorena Gandía

    (Nephrology Department, Hospital Clínico Universitario (INCLIVA), 46010 Valencia, Spain)

  • Sergio Romero-Alcaide

    (Nephrology Department, Hospital Clínico Universitario (INCLIVA), 46010 Valencia, Spain)

  • Elena Giménez-Civera

    (Nephrology Department, Hospital Clínico Universitario (INCLIVA), 46010 Valencia, Spain)

  • Pablo Molina

    (School of Medicine, Universidad de Valencia, 46010 Valencia, Spain
    Nephrology Department, Hospital Dr. Peset, FISABIO, 46017 València, Spain)

  • Nayara Panizo

    (Nephrology Department, Hospital Clínico Universitario (INCLIVA), 46010 Valencia, Spain
    School of Medicine, Universidad de Valencia, 46010 Valencia, Spain)

  • Javier Reque

    (Nephrology Department, Hospital de Castellón, 12004 Castellón, Spain)

  • José Luis Gorriz

    (Nephrology Department, Hospital Clínico Universitario (INCLIVA), 46010 Valencia, Spain
    School of Medicine, Universidad de Valencia, 46010 Valencia, Spain)

Abstract

Since the dramatic rise of the coronavirus infection disease 2019 (COVID-19) pandemic, patients receiving dialysis have emerged as especially susceptible to this infection because of their impaired immunologic state, chronic inflammation and the high incidence of comorbidities. Although several strategies have thus been implemented to minimize the risk of transmission and acquisition in this population worldwide, the reported severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence varies across studies but is higher than in the general population. On the contrary, the screening for hepatitis viruses (HBV and HCV) has seen significant improvements in recent years, with vaccination in the case of HBV and effective viral infection treatment for HCV. In this sense, a universal SARS-CoV-2 screening and contact precaution appear to be effective in preventing further transmission. Finally, regarding the progress, an international consensus with updated protocols that prioritize between old and new indicators would seem a reasonable tool to address these unexpended changes for the nephrology community.

Suggested Citation

  • Luis D’Marco & María Jesús Puchades & Miguel Ángel Serra & Lorena Gandía & Sergio Romero-Alcaide & Elena Giménez-Civera & Pablo Molina & Nayara Panizo & Javier Reque & José Luis Gorriz, 2021. "SARS-CoV-2 vs. Hepatitis Virus Infection Risk in the Hemodialysis Population: What Should We Expect?," IJERPH, MDPI, vol. 18(11), pages 1-6, May.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:11:p:5748-:d:563349
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/11/5748/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/11/5748/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Elizabeth J. Williamson & Alex J. Walker & Krishnan Bhaskaran & Seb Bacon & Chris Bates & Caroline E. Morton & Helen J. Curtis & Amir Mehrkar & David Evans & Peter Inglesby & Jonathan Cockburn & Helen, 2020. "Factors associated with COVID-19-related death using OpenSAFELY," Nature, Nature, vol. 584(7821), pages 430-436, August.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Brandily, Paul & Brébion, Clément & Briole, Simon & Khoury, Laura, 2021. "A poorly understood disease? The impact of COVID-19 on the income gradient in mortality over the course of the pandemic," European Economic Review, Elsevier, vol. 140(C).
    2. Borau, Sylvie & Couprie, Hélène & Hopfensitz, Astrid, 2022. "The prosociality of married people: Evidence from a large multinational sample," Journal of Economic Psychology, Elsevier, vol. 92(C).
    3. Anna Adamecz-Völgyi & Ágnes Szabó-Morvai, 2021. "Confidence in public institutions is critical in containing the COVID-19 pandemic," CERS-IE WORKING PAPERS 2126, Institute of Economics, Centre for Economic and Regional Studies.
    4. Shelly J. Robertson & Olivia Bedard & Kristin L. McNally & Carl Shaia & Chad S. Clancy & Matthew Lewis & Rebecca M. Broeckel & Abhilash I. Chiramel & Jeffrey G. Shannon & Gail L. Sturdevant & Rebecca , 2023. "Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    5. Dorn, Florian & Lange, Berit & Braml, Martin & Gstrein, David & Nyirenda, John L.Z. & Vanella, Patrizio & Winter, Joachim & Fuest, Clemens & Krause, Gérard, 2023. "The challenge of estimating the direct and indirect effects of COVID-19 interventions – Toward an integrated economic and epidemiological approach," Economics & Human Biology, Elsevier, vol. 49(C).
    6. McKee, Martin & Altmann, Danny & Costello, Anthony & Friston, Karl & Haque, Zubaida & Khunti, Kamlesh & Michie, Susan & Oni, Tolullah & Pagel, Christina & Pillay, Deenan & Reicher, Steve & Salisbury, , 2022. "Open science communication: The first year of the UK's Independent Scientific Advisory Group for Emergencies," Health Policy, Elsevier, vol. 126(3), pages 234-244.
    7. João Faro-Viana & Marie-Louise Bergman & Lígia A. Gonçalves & Nádia Duarte & Teresa P. Coutinho & Patrícia C. Borges & Christian Diwo & Rute Castro & Paula Matoso & Vanessa Malheiro & Ana Brennand & L, 2022. "Population homogeneity for the antibody response to COVID-19 BNT162b2/Comirnaty vaccine is only reached after the second dose across all adult age ranges," Nature Communications, Nature, vol. 13(1), pages 1-8, December.
    8. Martin S. Eichenbaum & Sergio Rebelo & Mathias Trabandt, 2022. "Inequality in Life and Death," IMF Economic Review, Palgrave Macmillan;International Monetary Fund, vol. 70(1), pages 68-104, March.
    9. Denis Mongin & Nils Bürgisser & Gustavo Laurie & Guillaume Schimmel & Diem-Lan Vu & Stephane Cullati & Delphine Sophie Courvoisier, 2023. "Effect of SARS-CoV-2 prior infection and mRNA vaccination on contagiousness and susceptibility to infection," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    10. Qinghong Fan & Jingrong Shi & Yanhong Yang & Guofang Tang & Mengling Jiang & Jiaojiao Li & Jingyan Tang & Lu Li & Xueliang Wen & Lieguang Zhang & Xizi Deng & Yaping Wang & Yun Lan & Liya Li & Ping Pen, 2022. "Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    11. Sakino Shinokawa & Hiroki Abe & Risa Takashima & Ryuta Onishi & Michiyo Hirano, 2023. "Verification of the Effectiveness of a Communication Application in Improving Social Connectedness and Physical Health among Unacquainted Older Men: A Mixed-Methods Pilot Study," IJERPH, MDPI, vol. 20(3), pages 1-15, January.
    12. Hiroshi Murayama & Isuzu Nakamoto & Takahiro Tabuchi, 2021. "Social Capital and COVID-19 Deaths: An Ecological Analysis in Japan," IJERPH, MDPI, vol. 18(20), pages 1-9, October.
    13. Ján Palguta & Levínský, René & Škoda, Samuel, 2021. "Do Elections Accelerate the COVID-19 Pandemic? Evidence from a Natural Experiment," GLO Discussion Paper Series 891, Global Labor Organization (GLO).
    14. Eran Mick & Alexandra Tsitsiklis & Natasha Spottiswoode & Saharai Caldera & Paula Hayakawa Serpa & Angela M. Detweiler & Norma Neff & Angela Oliveira Pisco & Lucy M. Li & Hanna Retallack & Kalani Ratn, 2022. "Upper airway gene expression shows a more robust adaptive immune response to SARS-CoV-2 in children," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    15. Uchechukwu Levi Osuagwu & Chikasirimobi G Timothy & Raymond Langsi & Emmanuel K Abu & Piwuna Christopher Goson & Khathutshelo P Mashige & Bernadine Ekpenyong & Godwin O Ovenseri-Ogbomo & Chundung Asab, 2021. "Differences in Perceived Risk of Contracting SARS-CoV-2 during and after the Lockdown in Sub-Saharan African Countries," IJERPH, MDPI, vol. 18(21), pages 1-12, October.
    16. Takanao Tanaka & Shohei Okamoto, 2021. "Increase in suicide following an initial decline during the COVID-19 pandemic in Japan," Nature Human Behaviour, Nature, vol. 5(2), pages 229-238, February.
    17. Lucy B. Cook & Gillian O’Dell & Eleni Vourvou & Renuka Palanicawandar & Sasha Marks & Dragana Milojkovic & Jane F. Apperley & Sandra Loaiza & Simone Claudiani & Marco Bua & Catherine Hockings & Donald, 2022. "Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies," Nature Communications, Nature, vol. 13(1), pages 1-6, December.
    18. Madia, Joan E. & Moscone, Francesco & Nicodemo, Catia, 2023. "Informal care, older people, and COVID-19: Evidence from the UK," Journal of Economic Behavior & Organization, Elsevier, vol. 205(C), pages 468-488.
    19. Zuzanna Kowalik & Piotr Lewandowski, 2021. "The gender gap in aversion to COVID-19 exposure: Evidence from professional tennis," PLOS ONE, Public Library of Science, vol. 16(3), pages 1-10, March.
    20. I. Gede Nyoman M. Jaya & Henk Folmer, 2021. "Bayesian spatiotemporal forecasting and mapping of COVID‐19 risk with application to West Java Province, Indonesia," Journal of Regional Science, Wiley Blackwell, vol. 61(4), pages 849-881, September.

    More about this item

    Keywords

    chronic kidney disease; hepatitis; SARS-CoV-2; COVID19; dialysis;
    All these keywords.

    JEL classification:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:11:p:5748-:d:563349. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.